🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Daniel D. Rhoads

Cleveland Clinic

ORCID: 0000-0002-7636-5191
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Genomic heterogeneity underlies multidrug resistance in Pseudomonas aeruginosa: A population-level analysis beyond susceptibility testing”.

Genomic heterogeneity underlies multidrug resistance in Pseudomonas aeruginosa: A population-level analysis beyond susceptibility testing

PLoS ONE(2022)10.1371/journal.pone.0265129
N/A
0.470DataRank · unranked
22 citations

Mohamad Yasmin, Jacquelynn Benjamino, Steven Marshall, Kailynn DeRonde, Nikhil Krishnan +17 more

Building the Model

Archives of Pathology & Laboratory Medicine(2022)10.5858/arpa.2021-0635-ra
N/A
0DataRank · unranked
34 citations

Daniel D. Rhoads, Jorge L. Sepulveda, Chengxi Zang, Amy Chadburn, Fei Wang +1 more

Partial ORF1ab Gene Target Failure with Omicron BA.2.12.1

medRxiv(2022)10.1101/2022.04.25.22274187
N/A
0DataRank · unranked
0 citations

David R. Peaper, Brendan J. Kelly, Frederic D. Bushman, Andrew D. Marques, Hriju Adhikari +18 more

A molecular analysis of meropenem–vaborbactam non-susceptible KPC-producing Klebsiella pneumoniae

Antimicrobial Agents and Chemotherapy(2024)10.1128/aac.00208-24
N/A
0DataRank · unranked
7 citations

Steven H. Marshall, Liang Chen, Daniel D. Rhoads, Michael R. Jacobs, Laura J. Rojas +10 more

ARGONAUT-III and -V: susceptibility of carbapenem-resistant Klebsiella pneumoniae and multidrug-resistant Pseudomonas aeruginosa to the bicyclic boronate β-lactamase inhibitor taniborbactam combined with cefepime

Antimicrobial Agents and Chemotherapy(2024)10.1128/aac.00751-24
N/A
0DataRank · unranked
14 citations

Ayman M. Abdelhamed, Caryn E. Good, Andrew R Mack, Christopher R. Bethel, Steven H. Marshall +12 more

ARGONAUT-IV: susceptibility of carbapenemase-producing Klebsiella pneumoniae to the oral bicyclic boronate β-lactamase inhibitor ledaborbactam combined with ceftibuten

Antimicrobial Agents and Chemotherapy(2024)10.1128/aac.01127-24
N/A
0DataRank · unranked
6 citations

Caryn E. Good, Ayman M. Abdelhamed, Andrew R Mack, Christopher R. Bethel, Steven H. Marshall +12 more

The Truth about SARS-CoV-2 Cycle Threshold Values Is Rarely Pure and Never Simple

Clinical Chemistry(2021)10.1093/clinchem/hvab146
N/A
0DataRank · unranked
39 citations

Benjamin A. Pinsky, Daniel D. Rhoads

ARGONAUT-IV: susceptibility of carbapenemase-producing Klebsiella pneumoniae to the oral bicyclic boronate β-lactamase inhibitor ledaborbactam combined with ceftibuten.

UNC Libraries(2025)10.17615/tde0-ye85
N/A
0DataRank · unranked
0 citations

Vance G. Fowler, Daniel D. Rhoads, Andrea M. Hujer, Robert A Bonomo, Christopher R. Bethel +12 more